Real-World COPD Management Over 3 Years at the Community Health Service Center of Shanghai During the COVID-19 Pandemic in China

References

• Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al.; China Pulmonary Health Study Group. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–1158. doi:10.1016/S0140-6736(19)30427-1
   PubMed Web of Science ®Google Scholar
• Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430.
   PubMed Web of Science ®Google Scholar
• Liang C, Mao X, Niu H, et al. Management and in-hospital clinical outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in China: results from the phase I data of ACURE study. Int J Chron Obstruct Pulmon Dis. 2021;16:451–465. doi:10.2147/COPD.S281957
   PubMed Web of Science ®Google Scholar
• Yang T, Cai B, Cao B, et al. REALizing and improving management of stable COPD in China: a multi-center, prospective, observational study to realize the current situation of COPD patients in China (REAL) - rationale, study design, and protocol. BMC Pulm Med. 2020;20(1):11. doi:10.1186/s12890-019-1000-x
   PubMedGoogle Scholar
• Li F, Gao Z, Sheng CF, et al. Role of smartphone-based D2P-COPD platform in the hierarchical diagnosis and treatment of chronic obstructive pulmonary disease. Chinese Gen Pract. 2018;21(30):3730–3734.
   Google Scholar
• McAuley H, Hadley K, Elneima O, et al. COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Res. 2021;7(1):718–2020. doi:10.1183/23120541.00718-2020
   Google Scholar
• COVID-19 Map. Johns Hopkins coronavirus resource center. Johns Hopkins Coronavirus Resource Center. Available from: https://coronavirus.jhu.edu/map.html. Accessed January 6, 2022.
   Google Scholar
• González J, Moncusí-Moix A, Benitez ID, et al. Clinical Consequences of COVID-19 lockdown in patients with COPD: results of a pre-post study in Spain. Chest. 2021;160(1):135–138. doi:10.1016/j.chest.2020.12.057
   PubMed Web of Science ®Google Scholar
• Hu W, Dong M, Xiong M, et al. Clinical courses and outcomes of patients with chronic obstructive pulmonary disease during the COVID-19 epidemic in Hubei, China. Int J Chron Obstruct Pulmon Dis. 2020;15:2237–2248. doi:10.2147/COPD.S265004
   PubMed Web of Science ®Google Scholar
• Price DB, Tinkelman DG, Nordyke RJ, et al.; COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129(6):1531–1539. doi:10.1378/chest.129.6.1531
   PubMed Web of Science ®Google Scholar
• International Primary Care Airway Group. Ipag diagnosis management handbook chronic airways disease A guide for primary care physician; 2016.
   Google Scholar
• Juan W, Wenbing X, Xuejun Z, et al. Initial validation and evaluation on a Chinese version of chronic obstructive pulmonary disease screening questionnaireinSmokers. Chin J Int Med. 2012;51(4):311–312.
   Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Wu Z, Huang R, Zhong L, et al. Technical performance analysis of different types of spirometers. BMC Pulm Med. 2022;22(1):23. doi:10.1186/s12890-021-01752-8
   PubMedGoogle Scholar
• Standardization of Spirometry, 1994 Update. American thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136. PMID: 7663792. doi:10.1164/ajrccm.152.3.7663792
   PubMed Web of Science ®Google Scholar
• Sarkar M, Srinivasa S, Madabhavi I, et al. Tuberculosis associated chronic obstructive pulmonary disease. Clin Respir J. 2017;11(3):285–295. doi:10.1111/crj.12621
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2020 report[EB/OL]; 2021. Available from: goldcopd.org/2022-gold-reports. Accessed March 8, 2023.
   Google Scholar
• Kim JA, Lim MK, Kim K, et al. Adherence to inhaled medications and its effect on healthcare utilization and costs among high-grade chronic obstructive pulmonary disease patients. Clin Drug Investig. 2018;38(4):333–340. doi:10.1007/s40261-017-0612-2
   PubMed Web of Science ®Google Scholar
• Feng J, Xu J, Xu S, et al. Psychological impact during the first outbreak of COVID-19 on frontline health care workers in Shanghai. Front Public Health. 2021;9:646780. doi:10.3389/fpubh.2021.646780
   PubMedGoogle Scholar
• Li ZY, Meng LY. Technical guidelines on prevention and control of novel coronavirus infec- tion in medical institutions (First edition). Chin J Infect Control. 2020;19(2):189–191.
   Google Scholar
• Kaye L, Theye B, Smeenk I, et al. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(7):2384–2385. doi:10.1016/j.jaip.2020.04.053
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. doi:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Jenkins CR. Towards precision in defining COPD exacerbations. Breathe. 2021;17(3):210081. doi:10.1183/20734735.0081-2021
   Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-196
   PubMed Web of Science ®Google Scholar
• Jenkins CR, Wen FQ, Martin A, et al. The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial. Eur Respir J. 2021;57(6):2003338. doi:10.1183/13993003.03338-2020
   PubMedGoogle Scholar
• Linnell J, Hurst JR, Exacerbations: COPD, Patient A. Physician’s Perspective. Adv Ther. 2020;37(1):10–16. doi:10.1007/s12325-019-01138-7
   PubMedGoogle Scholar
• Howcroft M, Walters EH, Wood-Baker R, et al. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12(12):CD005074. doi:10.1002/14651858.CD005074.pub4
   PubMedGoogle Scholar
• Vestbo J, Leather D, Diar Bakerly N, et al. Effectiveness of fluticasone furoate-vilanterol for COPD in clinical practice. N Engl J Med. 2016;375(13):1253–1260. doi:10.1056/NEJMoa1608033
   PubMed Web of Science ®Google Scholar
• Textor J, van der Zander B, Gilthorpe MS, et al. Robust causal inference using directed acyclic graphs: the R package ‘dagitty’. Int J Epidemiol. 2016;45(6):1887–1894. doi:10.1093/ije/dyw341
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.113662
   PubMed Web of Science ®Google Scholar
• Jansen EM, van de Hei SJ, Dierick BJH, et al. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers. J Thorac Dis. 2021;13(6):3846–3864. doi:10.21037/jtd-20-2360
   PubMed Web of Science ®Google Scholar
• Chan KPF, Ma TF, Kwok WC, et al. Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respir Med. 2020;171:106085. doi:10.1016/j.rmed.2020.106085
   PubMed Web of Science ®Google Scholar